酒石酸美托洛爾市場：依給藥途徑、應用、通路和地區分類

2026年，酒石酸美托洛爾市場規模估計為25億美元，預計2033年將達到40億美元。預計從2026年到2033年，其複合年成長率將達到8.7%。

酒石酸美托洛爾是一種選擇性BETA1受體阻斷劑，可透過降低心率和提高心臟泵血效率來治療心血管疾病和高血壓。它用於治療高血壓、因心臟血液供應不足引起的胸痛和心律不整。酒石酸美托洛爾主要用於治療心絞痛、心律不整和甲狀腺功能亢進。酒石酸美托洛爾有兩種劑型：口服和注射。酒石酸美托洛爾的學名藥是倍他樂克（Lopressor）。美托洛爾有速釋片和緩釋片兩種劑型，均設計為在體內崩壞並釋放藥物，兩種劑型均需處方箋。

市場動態

預計在預測期內，全球心血管疾病盛行率的不斷上升將推動全球酒石酸美托洛爾市場的發展。例如，根據2021年8月發布的歐洲統計數據，2019年德國約進行了45,400例搭橋手術。此外，2016年，歐洲地區有168萬人死於心血管疾病。同樣的心血管疾病盛行率數據顯示，25-34歲年齡層的高血壓盛行率上升，年齡層約有3.4%的歐洲人口患有高血壓。此外，超過54.6%的高血壓患者年齡在75歲以上，預計將推動未來幾年對酒石酸美托洛爾的需求。

本報告的主要特點

• 本報告對全球酒石酸美托洛爾市場進行了詳細分析，包括市場規模和預測期（2026-2033 年）的複合年成長率，以 2025 年為基準年。
• 此外，它還確定了每個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
• 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
• 本文根據以下參數，介紹了全球酒石酸美托洛爾市場主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
• 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
• 《全球酒石酸美托洛爾市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過分析全球酒石酸美托洛爾市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 影響分析
• 市場趨勢
• 主要進展
• 產品核准
• 商業夥伴關係、企業合併與收購 (M&A)
• 監理情勢
• PEST分析
• 波特五力分析
• 流行病學
• 強大的管道分析

第4章 全球酒石酸美托洛爾市場：依給藥途徑分類（2026-2033 年）

• 口服
• 注射

第5章 全球酒石酸美托洛爾市場：依應用領域分類（2026-2033 年）

• 高血壓
• 心血管疾病
• 其他

第6章 全球酒石酸美托洛爾市場：依分銷管道分類（2026-2033 年）

• 醫院藥房
• 零售藥房
• 網路藥房

第7章 全球酒石酸美托洛爾市場：按地區分類（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第8章 競爭情勢

• 熱圖分析
• 市佔率分析
• 公司簡介
  • Novartis Pharmaceuticals Canada Inc.
  • AstraZeneca Pharma India Limited
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Inc.
  • CTX Life Sciences Pvt. Ltd.
  • Hikma Pharmaceuticals PLC
  • Validus Pharmaceuticals LLC
  • Alembic Pharmaceuticals Limited
  • Aurobindo Pharma USA
  • Sandoz Canada Inc.
  • Apotex Inc.
  • Ipca Laboratories Ltd
  • Rubicon Research Pvt. Ltd.

第9章

• 參考
• 分析方法
• 關於 Coherent Market Insights

Metoprolol Tartrate Market is estimated to be valued at USD 2.5 Bn in 2026 and is expected to reach USD 4.0 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2033.

Metoprolol Tartrate is a selective B1 receptor blocker medication that is designed for the treatment of cardiovascular diseases and hypertension, as it works as slowing down the heart rate and makes the heart more efficient at pumping blood around the body. It is used for treating high blood pressure issues, chest pain due to low blood circulation to the heart, and abnormal heart rate. Metoprolol Tartrate is mostly used in the treatment of Angina pectoris, Cardiac arrhythmias, and thyrotoxicosis. Metoprolol Tartrate is available in two types of formulations including oral and injectable. The generic form of Metoprolol Tartrate is Lopressor. Metoprolol comes in form of immediate-release tablets which are designed to disintegrate and release medicine and extended-release tablets and it is prescribed medicine only.

Market Dynamics

Increasing prevalence of cardiovascular diseases in various region is expected to drive the global metoprolol tartrate market over the forecast period. For instance, in August 2021, European statistics published data on cardiovascular diseases, stating that in the year 2019, approximately 45,400 bypass surgeries were conducted in Germany. Moreover, in the year 2016, 1.68 million deaths occurred due to cardiovascular diseases in the Europe region. The same data on prevalence of cardiovascular diseases reported that high blood pressure increased in age group from 25 to 34 years and that around 3.4% of the population between this age group in Europe was reported to have hypertensive diseases. Furthermore, more than 54.6% population of hypertension diseases were aged 75 years or older, which is expected to drive demand for metoprolol tartrate in upcoming years.

Key features of the study

• This report provides an in-depth analysis of the global metoprolol tartrate market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global metoprolol tartrate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
• Key companies covered as a part of this study include Novartis Pharmaceuticals Canada Inc., AstraZeneca Pharma India Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Inc., CTX Life Sciences Pvt. Ltd., Hikma Pharmaceuticals PLC, Validus Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Aurobindo Pharma USA, Sandoz Canada Inc., Apotex Inc., Ipca Laboratories Ltd, and Rubicon Research Pvt. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global metoprolol tartrate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global metoprolol tartrate market.

Market Segmentation

• By Route of administration
  • Oral
  • Injectable
• By Application
  • Hypertension
  • Cardiovascular
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players
  • Novartis Pharmaceuticals Canada Inc.
  • AstraZeneca Pharma India Limited
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Inc.
  • CTX Life Sciences Pvt. Ltd.
  • Hikma Pharmaceuticals PLC
  • Validus Pharmaceuticals LLC
  • Alembic Pharmaceuticals Limited
  • Aurobindo Pharma USA
  • Sandoz Canada Inc.
  • Apotex Inc.
  • Ipca Laboratories Ltd
  • Rubicon Research Pvt. Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Product Approval
• Collaboration/Merge/Acquisition
• Regulatory Landscape
• PEST Analysis
• Porter's Five Forces Analysis
• Epidemiology
• Robust Pipeline Analysis

4. Global Metoprolol Tartrate Market, By Route of Administration, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

5. Global Metoprolol Tartrate Market, By Application, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Hypertension
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

6. Global Metoprolol Tartrate Market, By Distribution Channel, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

7. Global Metoprolol Tartrate Market, By Region, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
• Company Profile
  • Novartis Pharmaceuticals Canada Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • AstraZeneca Pharma India Limited
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Teva Pharmaceutical Industries Ltd.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Mylan N.V.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Dr. Reddy's Laboratories Ltd.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Sun Pharmaceutical Industries Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • CTX Life Sciences Pvt. Ltd.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Hikma Pharmaceuticals PLC
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Validus Pharmaceuticals LLC
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Alembic Pharmaceuticals Limited
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Aurobindo Pharma USA
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Sandoz Canada Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Apotex Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Ipca Laboratories Ltd
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Rubicon Research Pvt. Ltd.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
• Analyst Views

9. Section

• References
• Research Methodology
• About Us